Health care giant Johnson & Johnson expects about $400 million in tariff-related costs this year. The costs will be felt ...

Is it even 2025 if you’re not rethinking your crypto game? Forget the coins you missed. This new cycle’s already stirring, ...

We recently published a list of the 10 High Growth Forever Dividend Stocks to Invest In. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other ...

RBC Capital initiated coverage of Ascendis Pharma (ASND) with an Outperform rating and $205 price target. The stock has outperformed the ...

A good superhero needs a great logo. Done right, a superhero logo can become an instant icon and go on to become one of the ...

The topic of the month has been Tariffs. President Trump first announced them on April 2, in what he dubbed "Liberation Day".

*© 2025 Insider Inc. and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service and Privacy Policy.

Global drugmakers’ stocks dropped across the board today after U.S. President Donald Trump reiterated plans for a “major” ...

With broadcasts of the college football and NFL playoffs, as well as the men’s and women’s college basketball tournaments, many drugmakers looked to sports for advertising opportunities in Q1.

Trump on Tuesday said his administration will be announcing a “major” tariff on pharmaceuticals “very shortly.” ...